Material Agreements

Belpointe PREP, LLC entered into BPOZ Tokeneke Note with 100 Tokeneke Road, LLC valued at $5,000,000 (effective 2026-03-03).

“On March 3, 2026, Belpointe PREP, LLC (“we,” “us,” “our” or the “Company”), through our indirect wholly-owned subsidiary BPOZ 100 Tokeneke Holding, LLC, a Connecticut limited liability company (“BPOZ Tokeneke”), made a loan (the “BPOZ Tokeneke Loan”) in the principal amount of $5,000,000, evidenced by a convertible promissory note (the “BPOZ Tokeneke Note”), to 100 Tokeneke Road, LLC, a Connecticut limited liability company (“Tokeneke Road”).”

Edible Garden AG Inc entered into Packaging IOA with Tetra Pak Inc. (effective 2026-03-04).

“On March 4, 2026, Edible Garden AG Incorporated (the “Company”, “we” or “us”), entered into two Interim Order Agreements (the “IOAs”) with Tetra Pak Inc. (“Tetra Pak”).”

Edible Garden AG Inc entered into Processing IOA with Tetra Pak Inc. (effective 2026-03-04).

“On March 4, 2026, Edible Garden AG Incorporated (the “Company”, “we” or “us”), entered into two Interim Order Agreements (the “IOAs”) with Tetra Pak Inc. (“Tetra Pak”).”

Sono Group N.V. entered into Pre-Funded Warrant Securities Purchase Agreement with YA II PN, Ltd. (Yorkville) valued at $2,000,004.29 (effective 2026-03-10).

“On March 10, 2026, Sono Group N.V. (the “Company”) entered into a Pre-Funded Warrant Securities Purchase Agreement, dated March 10, 2026 (the “Securities Purchase Agreement”), between the Company and YA II PN, Ltd. (“Yorkville”), for a private placement (the “Private Placement”) of securities.”

AN2 Therapeutics, Inc. entered into Securities Purchase Agreement with certain investors valued at approximately $40 million (effective 2026-03-08).

“On March 8, 2026, AN2 Therapeutics, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain investors (the “Purchasers”).”

FutureTech II Acquisition Corp. amended Corrected D. Boral Note with D. Boral Capital, LLC valued at Corrected promissory note principal amount $1,475,000, contingency added (effective 2026-03-04).

“On March 4, 2026, the Company, Longevity and D. Boral corrected the mistake by executing a corrected promissory Note in the principal amount of $1,475,000 (the “Corrected D. Boral Note”).”

FutureTech II Acquisition Corp. entered into Engagement Letter with D. Boral Capital, LLC valued at D. Boral will serve as sole and exclusive financial advisor (effective 2026-03-04).

“On March 4, 2026, FutureTech II Acquisition Corp. (“FutureTech” or the “Company”) entered into an engagement letter (the “Engagement Letter”) with D. Boral Capital, LLC (“D. Boral”) pursuant to which both parties agreed that D. Boral will serve as the Company’s sole and exclusive financial advisor in connection with a De-SPAC business combination between Longevity Biomedical, Inc. (“Longevity”) and the Company (the “Business Combination”) announced in the Form S-4 registration statement dated February 14, 2025.”

Greenland Mines Ltd entered into Agreement and Plan of Merger with Greenland Mines Corp., a Delaware corporation valued at 47,000 newly issued shares of the Company’s Series C Preferred Stock (effective 2026-03-04).

“On March 4, 2026, Klotho Neurosciences, Inc. (the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Greenland Mines Corp., a Delaware corporation (“Greenland Mines”).”

TKO Group Holdings, Inc. amended Credit Agreement Amendment with Goldman Sachs Bank USA, as administrative agent valued at $900.0 million (effective 2026-03-10).

“On March 10, 2026 (the “Closing Date”), TKO Worldwide Holdings, LLC (“TKO Holdings”) (f/k/a UFC Holdings, LLC), an indirect subsidiary of TKO Group Holdings, Inc. (the “Company” or “TKO”), entered into an amendment (the “Credit Agreement Amendment”) to the First Lien Credit Agreement, dated as of August 18, 2016, among TKO Guarantor, LLC (f/k/a UFC Guarantor, LLC), as holdings, TKO Holdings, as borrower, Goldman Sachs Bank USA, as administrative agent, and the lenders party thereto”

Atlas Energy Solutions Inc. entered into Global Framework Agreement with Caterpillar Inc. valued at approximately $840 million (effective 2026-03-04).

“On March 4, 2026 (the “ Effective Date ”), Atlas Energy Solutions ProjectCo, LLC (“ ProjectCo ”), a Texas limited liability company and an indirect wholly owned subsidiary of Atlas Energy Solutions Inc. (the “ Company ”), a Delaware corporation, entered into the Global Framework Agreement (the “ GFA ”) with Caterpillar Inc. (“ Caterpillar ”) pursuant to which Caterpillar will reserve approximately 1.4 gigawatts (“ Reserved Capacity ”) of incremental power generation equipment (the “ Equipment ”) and ProjectCo will commit to purchase the Equipment from certain Caterpillar authorized dealers (“ Participating Dealers ”) based on ProjectCo’s monthly demand forecast beginning on the Effective Date and ending on December 31, 2030 (the “ Term ”) for an initial total aggregate purchase obligation of approximately $840 million.”

PennantPark Private Income Fund amended First Amendment to Senior Secured Revolving Credit Facility with CIBC Bank USA valued at Increased borrowing capacity from $65.0 million to $120.0 million (effective 2026-03-04).

“On March 4, 2026, ,PennantPark Private Income Fund SPV, LLC, a wholly-owned subsidiary of PennantPark Private Income Fund (the “Borrower”), entered into a first amendment (the “Amendment”) to its senior secured revolving credit facility, originally dated as of October 1, 2026 (the “Credit Facility”), by and among the Borrower, PennantPark Investment Advisers, LLC, as collateral manager, the lenders from time to time party thereto, CIBC Bank USA, as administrative agent, and Western Alliance Trust Company, National Association, as collateral agent. The Amendment increases the Credit Facility borrowing capacity from $65.0 million to $120.0 million.”

CLOROX CO /DE/ entered into 364-Day Revolving Credit Agreement with JPMorgan Chase Bank, N.A., Citibank, N.A., and Wells Fargo Bank, National Association valued at $1,000,000,000 (effective 2026-03-06).

“On March 6, 2026, in connection with the purchase of all of the issued and outstanding membership interests of GOJO Industries, Inc. (“GOJO”), maker of PURELL® (the “Gojo Acquisition”), pursuant to a membership interest purchase agreement (the “Acquisition Agreement”), by and among The Clorox Company (the “Company”), GOJO Industries Holdings, Inc., GOJO and certain shareholders, the Company entered into (i) a $1,000,000,000 364-day revolving credit agreement (the “364-Day Revolving Credit Agreement”) among JPMorgan Chase Bank, N.A., Citibank, N.A., and Wells Fargo Bank, National Association, as administrative agents and lenders, and the other agents and lenders party thereto”

AIR T INC entered into Share Purchase Agreement with Arena, the sellers party thereto (collectively, the "Sellers"), and Dirk Jan Smit, as Securityholders' Agent valued at approximately $20 million (effective 2026-03-08).

“On March 8, 2026, the Company, through Crestone Air Partners, Inc. (the “ Purchaser ” or “ Crestone ”), entered into a Share Purchase Agreement (the “ Purchase Agreement ”) with Arena, the sellers party thereto (collectively, the “ Sellers ”), and Dirk Jan Smit, as Securityholders’ Agent, pursuant to which Purchaser agreed to acquire all of the outstanding shares of Arena.”

WELLTOWER INC. amended Amended and Restated Credit Agreement with a consortium of 32 banks; KeyBank National Association, as administrative agent valued at $6,250,000,000 unsecured revolving credit facility (effective 2026-03-06).

“On March 6, 2026, Welltower OP LLC (the “Borrower”), a subsidiary of Welltower Inc. (the “Company”), entered into the Amended and Restated Credit Agreement, dated as of March 6, 2026 (the “Amended Credit Agreement”), with a consortium of 32 banks; KeyBank National Association, as administrative agent and L/C issuer; BofA Securities, Inc., JPMorgan Chase Bank, N.A. and Wells Fargo Securities LLC, as joint bookrunners for the Revolving A Facility and the Revolving B Facility”

Encompass Health Corp entered into 2026 Collateral and Guarantee Agreement with Truist Bank, as collateral agent (effective 2026-03-09).

“Additionally, the Company terminated its existing collateral and guarantee agreement with Barclays and entered into the Collateral and Guarantee Agreement (the “2026 Collateral and Guarantee Agreement”), by and among the Company, certain of its subsidiaries, and Truist Bank, as collateral agent, which provides for similar terms in all material respects.”

Encompass Health Corp terminated 2022 Credit Agreement with Barclays Bank PLC, as administrative agent and collateral agent, and various other lenders (effective 2026-03-09).

“As disclosed in Item 1.01 of this Current Report on Form 8-K, on March 9, 2026, the Company terminated the 2022 Credit Agreement and the Second Amended and Restated Collateral and Guarantee Agreement, dated November 25, 2019, by and among the Company, certain of its subsidiaries, and Barclays, as collateral agent.”

Encompass Health Corp entered into 2026 Credit Agreement with Truist Bank, as administrative agent and collateral agent, and various other lenders valued at $1 billion (effective 2026-03-09).

“On March 9, 2026 (the “Closing Date”), Encompass Health Corporation (the “Company”) entered into the Credit Agreement (the “2026 Credit Agreement”), by and among the Company, certain of its subsidiaries, as guarantors, Truist Bank, as administrative agent and collateral agent, and various other lenders.”

ACURA PHARMACEUTICALS, INC entered into Note with Abuse Deterrent Pharma, LLC valued at $100,000 (effective 2026-02-06).

“On each of February 6, 2026, February 13, 2026 and March 9, 2026, we received loans of $100,000 from Abuse Deterrent Pharma, LLC ("AD Pharma").”

HALLADOR ENERGY CO terminated Existing Credit Agreement with PNC Bank, National Association with PNC Bank, National Association valued at Termination effective March 5, 2026; no termination penalties (effective 2026-03-05).

“In connection with the Company’s entry into the Credit Agreement, on March 4, 2026, the Company delivered written notice to PNC Bank, National Association to terminate the Company’s Existing Credit Agreement, effective as of March 5, 2026.”

HALLADOR ENERGY CO entered into Credit Agreement with Texas Capital Bank valued at $75 million senior secured revolving credit facility and $45 million senior secured term loan facili (effective 2026-03-05).

“On March 5, 2026, Hallador Energy Company (the “Company”) entered into a Credit Agreement (the “Credit Agreement”), among the Company, Texas Capital Bank, as administrative agent (the “Agent”), swingline lender and letter of credit issuer, Old National Bank, as joint lead arranger and letter of credit issuer, First Financial Bank, N.A., as lender, each other lender from time to time party thereto, and each other letter of credit issuer from time to time party thereto, pursuant to which the Company obtained (i) a $75 million senior secured revolving credit facility (the “Revolving Credit Facility”) and (ii) a $45 million senior secured term loan facility (the “Delayed Draw Term Loan Facility” and, together with the Revolving Credit Facilities, the “Facilities”).”

AECOM amended Amendment No. 16 to Syndicated Facility Agreement with Bank of America, N.A. as administrative agent, swing line lender and an L/C issuer and the lenders party thereto valued at $1.5 billion revolving credit facility, $950 million term loan A facility, $500 million term loan B (effective 2026-03-10).

“On March 10, 2026 (the “ Amendment Effective Date ”), AECOM entered into that certain Amendment No. 16 to Syndicated Facility Agreement (the “ Amendment ”), by and among AECOM, as borrower, certain subsidiaries of AECOM, as guarantors, the lenders party thereto (the “ Lenders ”) and Bank of America, N.A. (the “ Administrative Agent ”) as administrative agent, swing line lender and an L/C issuer”

GENESIS ENERGY LP terminated Seventh Amended and Restated Credit Agreement with Genesis Energy, L.P. valued at Termination of the Old Credit Agreement effective upon entry into the New Credit Agreement (effective 2026-03-04).

“Entry into a Material Definitive Agreement On March 4, 2026, Genesis Energy, L.P. (“ Genesis ”) entered into an Eighth Amended and Restated Credit Agreement (the “ New Credit Agreement ”), among Genesis, as the borrower, Wells Fargo Bank, National Association, as administrative agent (in such capacity, the “ Administrative Agent ”) and issuing bank, Bank of America, N.A., as syndication agent, and the lenders and other parties party thereto.”

GENESIS ENERGY LP entered into Eighth Amended and Restated Credit Agreement with Wells Fargo Bank, National Association valued at $900 million senior secured revolving facility, up to $1.3 billion with lender consent (effective 2026-03-04).

“On March 4, 2026, Genesis Energy, L.P. (“ Genesis ”) entered into an Eighth Amended and Restated Credit Agreement (the “ New Credit Agreement ”), among Genesis, as the borrower, Wells Fargo Bank, National Association, as administrative agent (in such capacity, the “ Administrative Agent ”) and issuing bank, Bank of America, N.A., as syndication agent, and the lenders and other parties party thereto.”

SLM Corp entered into Agreement with Goldman Sachs & Co. LLC valued at $200 million (effective 2026-03-09).

“On March 9, 2026, SLM Corporation (the “Company”) entered into an accelerated share repurchase agreement with Goldman Sachs & Co. LLC ("Goldman Sachs") under which the Company will purchase $200 million of its own outstanding common stock, par value $0.20 per share (the "Common Stock").”

VALERO ENERGY CORP/TX entered into Underwriting Agreement with SMBC Nikko Securities America, Inc., Citigroup Global Markets Inc., MUFG Securities Americas Inc. and Wells Fargo Securities, LLC, as representatives of the several underwriters valued at $850,000,000 aggregate principal amount of its 5.150% Senior Notes due 2036 (effective 2026-03-05).

“On March 5, 2026, Valero Energy Corporation (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with SMBC Nikko Securities America, Inc., Citigroup Global Markets Inc., MUFG Securities Americas Inc. and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein, relating to the issuance and sale of $850,000,000 aggregate principal amount of its 5.150% Senior Notes due 2036 (the “Notes”).”

UNITED THERAPEUTICS Corp entered into Collared Accelerated Share Repurchase Agreement with Citibank, N.A. valued at $750,000,000 (effective 2026-03-09).

“Under the Collared ASR, which is being entered into pursuant to the Master Confirmation between the Company and Citi, dated August 1, 2025, the Company will receive an initial delivery of approximately 708,657 shares of Common Stock on March 11, 2026 representing approximately 50% of the total shares that would be repurchased under the Collared ASR (the Initial Delivery Amount ), measured based on the closing price of the Common Stock on March 9, 2026.”

UNITED THERAPEUTICS Corp entered into Uncollared Accelerated Share Repurchase Agreement with Citibank, N.A. valued at $750,000,000 (effective 2026-03-09).

“Under the Uncollared ASR, which is being entered into pursuant to the Master Confirmation between the Company and Citi, dated March 25, 2024, the Company will receive an initial delivery of approximately 992,120 shares of Common Stock on March 11, 2026 representing approximately 70% of the total shares that would be repurchased under the Uncollared ASR, measured based on the closing price of the Common Stock on March 9, 2026.”

NETLIST INC amended First Amendment to Lease with University Research Park LLC (effective 2026-03-04).

“On March 4, 2026, Netlist, Inc. (the “Company”) entered into a First Amendment to Lease (the “Lease Amendment”) with University Research Park LLC (the “Landlord”), pursuant to which the Company and the Landlord agreed to renew the Company’s existing lease dated April 28, 2021 (the “Lease”), relating to the Company’s corporate headquarter located at 111 Academy, Suite 100, Irvine, CA 92617 (the “Premises”).”

BATTALION OIL CORP entered into Securities Purchase Agreement with an institutional investor valued at aggregate gross proceeds of $15.0 million (effective 2026-03-03).

“On March 3, 2026, Battalion Oil Corporation (the “ Company ”), entered into a securities purchase agreement (the “ Securities Purchase Agreement ”) with an institutional investor (the “ Purchaser ”).”

Xencor Inc terminated Amended and Restated Collaboration and License Agreement with Genentech, Inc. and F. Hoffmann-La Roche Ltd (effective 2026-09-04).

“On March 4, 2026, Xencor, Inc. (the “Company”) received a notice of termination of an Amended and Restated Collaboration and License Agreement (the “Agreement”), effective as of June 1, 2024, with Genentech, Inc. (“GNE”) and F. Hoffmann-La Roche Ltd (“Roche” and, GNE and Roche, collectively, “Genentech”), pursuant to which Genentech has elected to terminate the Agreement in its entirety for convenience. The effective date of the termination of the Agreement is September 4, 2026.”

Bunker Hill Mining Corp. entered into Warrant Indenture with Computershare Trust Company of Canada valued at Governs issuance and management of warrants; each whole warrant exercisable at C$0.30 per share on o (effective 2026-03-05).

“In connection with the issuance of the Warrants, on March 5, 2026, the Company entered into a warrant indenture (the “ Warrant Indenture ”) with Computershare Trust Company of Canada, as warrant agent, to govern the issuance and management of the Warrants.”

Bunker Hill Mining Corp. entered into Subscriber Forms with Investors in LIFE Offering valued at Issuance of 159,735,000 LIFE Units at C$0.18 per Unit for gross proceeds of approximately C$33,752,3 (effective 2026-03-05).

“On March 5, 2026, the Company entered into a series of substantially similar subscriber forms (collectively, the “ Subscriber Forms ”) pursuant to which such investors acquired LIFE Units at the Offer Price.”

Bunker Hill Mining Corp. entered into Agency Agreement with Haywood Securities Inc., Roth Canada, Inc., BMO Capital Markets, Canaccord Genuity Corp. valued at aggregate cash fees of approximately C$1,627,110 and issuance of 9,039,500 non-transferable compensa (effective 2026-03-05).

“On March 5, 2026, the Company and Haywood, on its own behalf and on behalf of Roth Canada, Inc., BMO Capital Markets, and Canaccord Genuity Corp. (collectively, the “ Agents ”), entered into an agency agreement (the “ Agency Agreement ”), pursuant to which the Agents conducted the LIFE Offering.”

TPI COMPOSITES, INC entered into ECP Purchase Agreement with ECP Blade Holdings LLC valued at $20,000,000 in cash (effective 2026-03-06).

“On March 6, 2026, the Company and certain of its direct and indirect subsidiaries (collectively, the “ECP Seller Parties”) entered into a Stock and Asset Purchase Agreement (the “ECP Purchase Agreement”) with ECP Blade Holdings LLC (“ECP Buyer”).”

LiveOne, Inc. entered into Shares Issuance Agreement with Music and Entertainment Rights Licensing Independent Network Limited ("Merlin") valued at 500,000 shares of its common stock, $0.001 par value per share, at a deemed issued price of $7.50 pe (effective 2026-03-03).

“On March 3, 2026, LiveOne, Inc. (the “Company”), Slacker, Inc. (“Slacker”), the Company’s wholly owned subsidiary, and Music and Entertainment Rights Licensing Independent Network Limited (“Merlin”) entered into a Shares Issuance Agreement (the “Agreement”) pursuant to which the Company agreed to issue to Merlin 500,000 shares (the “Shares”) of its common stock, $0.001 par value per share (the “common stock”), at a deemed issued price of $7.50 per share.”

Sunoco LP entered into Indenture with U.S. Bank Trust Company, National Association, as trustee valued at $1,200 million aggregate principal amount of Senior Notes (5.375% due 2031 and 5.625% due 2034) (effective 2026-03-09).

“On March 9, 2026, Sunoco LP (NYSE: SUN) (the “ Partnership ”) completed a private offering to eligible purchasers (the “ Notes Offering ”) of (i) $600 million in aggregate principal amount of its 5.375% Senior Notes due 2031 (the “ 2031 Notes ”) and (ii) $600 million in aggregate principal amount of its 5.625% Senior Notes due 2034 (the “ 2034 Notes ” and, collectively with the 2031 Notes, the “ Notes ”), along with the related guarantees of the Notes.”

RELMADA THERAPEUTICS, INC. entered into Securities Purchase Agreement with certain institutional and accredited investors valued at approximately $160.0 million (effective 2026-03-09).

“On March 9, 2026, Relmada Therapeutics, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) for a private placement (the “Private Placement”) with certain institutional and accredited investors (each, a “Purchaser” and collectively, the “Purchasers”).”

WYTEC INTERNATIONAL INC entered into 1800 Diagonal SPA with 1800 Diagonal Lending LLC valued at $71,300 (effective 2026-03-03).

“entered into a securities purchase agreement (the “1800 Diagonal SPA”) with 1800 Diagonal Lending LLC, a Virginia limited liability company (“1800 Diagonal”), which closed on March 3, 2026, pursuant to which Wytec sold 1800 Diagonal a promissory note in the principal amount of $71,300”

Envirotech Vehicles, Inc. entered into Warrants with YA II PN, Ltd. (effective 2026-03-06).

“the Company issued to the Buyer warrants to purchase up to 1,291,778 shares of Common Stock at an exercise price of $0.01 per share (the “Warrants”)”

Envirotech Vehicles, Inc. entered into Debentures with YA II PN, Ltd. valued at $11,000,000 (effective 2026-03-06).

“in the aggregate principal amount of $11,000,000 (the “Subscription Amount”) in two tranches with the purchase price of the Debentures in each tranche being equal to 96% of the Subscription Amount to be purchased.”

Envirotech Vehicles, Inc. entered into Purchase Agreement with YA II PN, Ltd. valued at $11,000,000 (effective 2026-03-06).

“On March 6, 2026, Envirotech Vehicles, Inc., a Delaware corporation (the “Company”), entered into a securities purchase agreement (the “Purchase Agreement”) with YA II PN, Ltd. (the “Buyer”), pursuant to which the Company agreed to issue and sell to the Buyer, and the Buyer agreed to purchase from the Company, debentures (the “Debentures”) in the aggregate principal amount of $11,000,000 (the “Subscription Amount”) in two tranches”

REALLOYS INC. entered into Underwriting Agreement with Clear Street LLC (effective 2026-03-05).

“On March 5, 2026, REalloys Inc. (the “ Company ”) entered into an underwriting agreement (the “ Underwriting Agreement ”) with Clear Street LLC”

Jaguar Health, Inc. terminated Warrant Termination Agreement with Uptown Capital, LLC, Streeterville Capital, LLC, Iliad Research and Trading, L.P. (effective 2026-03-06).

“On March 6, 2026, the Company entered into a warrant termination agreement (the “Warrant Termination Agreement”) with Uptown, Streeterville, and Iliad Research and Trading, L.P. (“Iliad”; and together with Uptown and Streeterville, collectively the “Investors”), pursuant to which, warrants exercisable into an aggregate of 48,211 shares of the Company’s voting common stock, par value $0.0001 per share (the “Common Stock”) previously issued by the Company to the Investors would be terminated.”

Jaguar Health, Inc. amended 2025 Note Amendment with Streeterville Capital, LLC valued at $7,048,021.86 (effective 2026-03-06).

“On March 6, 2026, the Company also entered into an amendment (the “2025 Note Amendment”) with Streeterville to the secured promissory note in the original principal amount of $10,810,000.00 (the “2025 Note”) issued by the Company to Streeterville on November 12, 2025 pursuant to that certain Note Purchase Agreement among the same parties dated as of the even date.”

Jaguar Health, Inc. amended 2021 Note Amendment No. 3 with Streeterville Capital, LLC valued at $6,596,304.11 (effective 2026-03-06).

“On March 6, 2026, the Company and Napo Pharmaceuticals, Inc., the Company’s wholly-owned subsidiary (“Napo” and together with the Company, the “Borrower”), entered into an amendment (the “2021 Note Amendment No. 3”) with Streeterville to the secured promissory note in the original principal amount of $6,220,812.50 (as amended, the “2021 Note”) issued by Borrower to Streeterville on January 19, 2021 pursuant to that certain Note Purchase Agreement among the same parties dated as of the even date.”

Jaguar Health, Inc. amended Streeterville 2022 Royalty Interest Global Amendment No. 4 with Streeterville Capital, LLC valued at $12,428,782.20 (effective 2026-03-06).

“On March 6, 2026, the Company also entered into an amendment (the “Streeterville 2022 Royalty Interest Global Amendment No. 4”) to the royalty interest in the original principal amount of $12 million, as amended (the “Streeterville 2022 Royalty Interest”) with Streeterville Capital, LLC (“Streeterville”), pursuant to which, (i) the starting date for the Company to make the monthly Royalty Payment under the Streeterville 2022 Royalty Interest would be postponed from April 1, 2026 to July 1, 2026, and (ii) the Royalty Repayment Amount (as defined in the Streeterville 2022 Royalty Interest) would be reduced by ten percent.”

Jaguar Health, Inc. amended Uptown 2020 Royalty Interest Global Amendment No. 4 with Uptown Capital, LLC valued at $11,125,282.54 (effective 2026-03-06).

“On March 6, 2026, Jaguar Health, Inc. (the “Company”) entered into an amendment (the “Uptown 2020 Royalty Interest Global Amendment No. 4”) to the royalty interest in the original principal amount of $12 million, as amended (the “Uptown 2020 Royalty Interest”) with Uptown Capital, LLC (f/k/a Irving Park Capital, LLC; “Uptown”), as amended, pursuant to which, (i) the starting date for the Company to make the monthly Royalty Payment under the Uptown 2020 Royalty Interest would be postponed from April 1, 2026 to July 1, 2026, and (ii) the Royalty Repayment Amount (as defined in the Uptown 2020 Royalty Interest) would be reduced by ten percent.”

CACI INTERNATIONAL INC /DE/ amended Amendment No. 1 with JPMorgan Chase Bank, N.A., as administrative agent and the lenders party thereto valued at $800 million (effective 2026-03-09).

“On March 9, 2026, CACI International Inc (the “Company”) and certain of its subsidiaries entered into Amendment No. 1 (the “Amendment”) to that certain Credit Agreement, dated as of October 30, 2024 (as amended, the “Term Loan B Credit Agreement”), with the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent. The Amendment provides for an additional $800 million tranche of incremental term loans (the “Incremental Term B-2 Loans”) under the Term Loan B Credit Agreement with a maturity date of March 9, 2033.”

Ondas Inc. entered into Agreement and Plan of Merger with Mistral, Inc. and Shoshana Banai valued at Total consideration of $175,000,000 payable in shares of common stock, with portions escrowed and pa (effective 2026-03-08).

“On March 8, 2026, Ondas Inc. (the “Company”) entered into an Agreement and Plan of Merger (the “Agreement”), by and among the Company, Project Cyclone Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of the Company (“Merger Sub”), Mistral, Inc., a Delaware corporation (“Mistral”), and Shoshana Banai (the “Stockholder”).”

SPRUCE BIOSCIENCES, INC. terminated Prior Sales Agreement with Jefferies LLC (effective 2026-03-09).

“(the “Company”) entered into an Open Market Sale Agreement SM (the “Sales Agreement”) with Jefferies LLC (“Jefferies”). Under the Sales Agreement, the Company may offer and sell, from time to time, through Jefferies as its sales agent and/or principal, shares (the “Shares”) of its common stock, par value $0.0001 per share (the “Common Stock”), having an aggregate offering amount not exceeding the Maximum Program Amount, as such term is defined in the Sales Agreement.”